Please use Bharat Immunologicals fundamental data analysis to find out if markets are presently mispricing the company. We found twenty-three available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income . Use Bharat Immunologicals to protect your portfolios against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Bharat Immunologicals to be traded at 8.35 in 30 days.
Bharat Immunologicals Company Summary
Bharat Immunologicals competes with Biocon, Biocon, Syngene International, Sequent Scientific, and Panacea Biotec. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.
Bharat Immunologicals Beta vs Gross Profit
Bharat Immunologicals Biologicals Corp Ltd is rated below average in beta category among related companies. It is rated below average in gross profit category among related companies fabricating about 175,651,163 of Gross Profit per Beta.
Bharat Immunologicals Systematic Risk